Molecular approaches in obesity studies

Gastroenterology and Hepatology from Bed to Bench

Volumn 6, Issue SUPPL., 2013, Pages

  Zamanian Azodi, Mona ^a   Vafaee, Reza ^a   Azodi, Taghi ^a   Omidi, Roghiyeh ^a   Gilanchi, Samira ^b   Azizi Jalilian, Farid ^c   Khodarahmi, Reza ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genomics; Metabolomics; Molecular detection; Obesity; Proteomics

Indexed keywords

BRCA1 PROTEIN; C REACTIVE PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYSTATIN C; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELATINASE A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 6; PENTRAXIN; PROTEIN P53; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN;

ADIPOCYTE; ALZHEIMER DISEASE; BREAST CANCER; CANCER RISK; GENE; GENE EXPRESSION; GENOMICS; HEART DISEASE; HUMAN; INSULIN RESISTANCE; KCTD15 GENE; METABOLOMICS; MOLECULAR DIAGNOSIS; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PREVALENCE; PROTEOMICS; REVIEW; ZFP36 GENE;

EID: 84888806852     PISSN: 20082258     EISSN: 20084234     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Thomas DM, Weedermann M, Fuemmeler BF, Martin CK, Dhurandhar NV, Bredlau C, et al. Dynamic model predicting overweight, obesity, and extreme obesity prevalence trends. Obesity 2013 Jun 26.
2. Williams DJ, Edwards D, Hamernig I, Jian L, James AP, Johnson SK, et al. Vegetables containing phytochemicals with potential anti-obesity properties: A review. Food Res Int 2013; 52:323-33.
3. Kussmann M, Affolter M. Proteomics and metabonomics routes towards obesity. In: Sorensen TIA, Clément K, editores. Obesity- genomics and postgenomics. 1st edition. New York: Informa Healthcare; 2008. P.527-36.
4. Barceló O, Batllori S, Gomis R. Proteomics in obesity research. Prot Clin Appl 2009;3:263-78.
5. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur heart J 2008;29:2959-71.
6. van der Steeg JW, Steures P, Eijkemans MJ, Habbem a JDF, Hompes PG, BurggraaffJM, et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod 2008;23:324-28.
7. Pischon N, Heng N, Bernimoulin J-P, Kleber B-M, Willich S, Pischon T. Obesity, inflammation, and periodontal disease. JDR 2007;86:400-409.
8. Preiss K, Brennan L, Clarke D. A systematic review of variables associated with the relationship between obesity and depression. Obes Rev. 2013 Jun 30.
9. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005;288:2031-41.
10. Amadou A, Ferrari P, Muwonge R, Moskal A, Biessy C, Romieu I, et al. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose response metaanalysis. Obes Rev 2013 Jun 30.
11. Kolotkin RL, Binks M, Crosby RD, Østbye T, Gress RE, Adams TD. Obesity and sexual quality of life. Obesity 2006;14:472-79.
12. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-19.
13. Mariman EC, Wang P. Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell Mol Life Sci 2010;67:1277-92.
14. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, et al. Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995;44:855-58.
15. Palou A, Serra F, Bonet M, Pico C. Obesity: molecular bases of a multifactorial problem. Eur J Nutr 2000;39:127-44.
16. Campfield LA, Smith FJ, Burn P. Strategies and potential molecular targets for obesity treatment. Science1998;280:1383-87.
17. Woods S, Seeley R. Understanding the physiology of obesity: review of recent developments in obesity research. International journal of obesity and related metabolic disorders. Int J Obes 2002;26:8-10.
18. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307-12.
19. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195-200.
20. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 1994;43:1271-78.
21. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95:2409.
22. Kawano J, Arora R. The role of adiponectin in obesity, diabetes, and cardiovascular disease. JCMS 2009;4:44-49.
23. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. JCEM 2001;86:1930-35.
24. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003;348:1625-38.
25. Lynch BM, Neilson HK, Friedenreich CM. Physical activity and breast cancer prevention. Physical Activity and Cancer 2011;186: 13-42.
26. Rezaei-Tavirani M, Zamanian-Azodi M, Azizi-Jalilian F, Khodakarim S. Biomarker Profiling (Erbb2, P53, and PR) for Stage I of Breast Cancer. Journal of Paramedical Sciences 2013;4:46-49
27. Zamanian Azodi M, Ardestani H, Dolat E, Mousavi M, Fayazfar S, Shadloo A. Breast Cancer: Genetics, Risk factors, Molecular Pathology and Treatment. Journal of Paramedical Sciences 2013;4:112-120.
28. Safaei A, Rezaei-Tavirani M, Sobhi S, Akbari ME. Breast Cancer Biomarker Discovery: Proteomics and Genomics Approaches. Iran J Cancer Prev 2013;6:45-53.
29. Zamanian-Azodi M, Rezaei-Tavirani M, Mortazavian A, Vafaee R, Rezaei-Tavirani M, Zali H, et al. Application of Proteomics in Cancer Study. American Journal of Cancer Science 2013;2:116-34.
30. Lorincz A, Sukumar S. Molecular links between obesity and breast cancer. Endocor Relat Cancer 2006;13:279-92.
31. Grossmann ME, Ray A, Nkhata KJ, Malakhov DA, Rogozina OP, Dogan S, et al. Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metast Rev 2010;29:641-53.
32. Jardé T, Perrier S, Vasson M-P, Caldefie-Chézet F. Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer 2011;47:33-43.
33. Brown KA, Simpson ER. Obesity and breast cancer: progress to understanding the relationship. Cancer Res 2010;70:4-7.
34. Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease: a review. Int J Epidemiol 1997;26:1-13.
35. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med 2002;347:305-13.
36. Azimi A, Charlot MG, Torp-Pedersen C, Gislason GH, Køber L, Jensen LO, et al. Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease. Heart 2013;99:655-60.
37. De Schutter A, Lavie CJ, Arce K, Menendez SG, Milani RV. Correlation and discrepancies between obesity by body mass index and body fat in patients with coronary heart disease. J Cardiopulm Rehabil Prev 2013;33:77-83.
38. Winter Y, Sankowski R, Back T. Genetic determinants of obesity and related vascular diseases. Vitam Horm 2012;91:29-48.
39. Factor-Litvak P. Maternal obesity and heart disease in the offspring. BMJ 2013;347.
40. Soheili Kashani M, Rezaei Tavirani M, Talaei SA, Salami M. Aqueous extract of lavender (Lavandula angustifolia) improves the spatial performance of a rat model of Alzheimer's disease. Neurosci bull 2011;27:99-106.
41. Zali H, Rezaei Tavirani M, Jalilian FA, Khodarahmi R. Proteins expression clustering of Alzheimer disease in rat hippocampus proteome. Journal of Paramedical Sciences 2013;4:112-18
42. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 2011;10:819-28.
43. Profenno LA, Porsteinsson AP, Faraone SV. Metaanalysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 2010;67:505-12.
44. Luchsinger JA, Cheng D, Tang MX, Schupf N, Mayeux R. Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord 2012;26:101-105.
45. Fewlass DC, Noboa K, Pi-Sunyer FX, Johnston JM, Yan SD, Tezapsidis N. Obesity-related leptin regulates Alzheimer's Aβ. FASEB J 2004;18:1870-78.
46. Ahima RS. Connecting Leptin and Alzheimer Disease. Arch Neurol 2010;67:873.
47. Razay G, Vreugdenhil A, Wilcock G. Obesity, abdominal obesity and Alzheimer disease. Dement Geriatr Cogn Disord 2006;22:173-76.
48. Xu W, Atti A, Gatz M, Pedersen N, Johansson B, Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk A population-based twin study. Neurology 2011;76:1568-74.
49. Puig KL, Floden AM, Adhikari R, Golovko MY, Combs CK. Amyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat dietinduced obesity. PloS One 2012;7:30378.
50. Martins IJ, Lim WLF, Wilson AC, Laws SM, Martins RN. The acceleration of aging and Alzheimer's disease through the biological mechanisms behind obesity and type II diabetes. Health 2013;5:913-20.
51. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
52. Knol M, Twisk J, Beekman A, Heine R, Snoek F, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006;49:837-45.
53. Elme A, Utriainen M, Kellokumpu-Lehtinen P, Palva T, Luoto R, Nikander R, et al. Obesity and Physical Inactivity Are Related to Impaired Physical Health of Breast Cancer Survivors. Anticancer Res 2013;33:1595-602.
54. Gohring JT, Dale PS, Fan X. Detection of HER2 breast cancer biomarker using the opto-fluidic ring resonator biosensor. Sensors and Actuators B 2010;146:226-30.
55. Zhu H, Dale PS, Caldwell CW, Fan X. Rapid and label-free detection of breast cancer biomarker CA15-3 in clinical human serum samples with optofluidic ring resonator sensors. Anal Chem 2009;81:9858-65.
56. Shustak RJ, McGuire SB, October TW, Phoon CK, Chun AJ. Prevalence of obesity among patients with congenital and acquired heart disease. Pediatr Cardiol 2012;33:8-14.
57. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
58. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engström G, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009;302:49-57.
59. Hollan I, Nebuloni M, Bottazzi B, Mikkelsen K, Førre ØT, Almdahl SM, et al. Pentraxin 3, a novel cardiovascular biomarker, is expressed in aortic specimens of patients with coronary artery disease with and without rheumatoid arthritis. Cardiovasc Pathol 2013;22: 324-31.
60. Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev 2013;35:152-60.
61. Cataldo JK, Prochaska JJ, Glantz SA. Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation. J Alzheimers Dis 2010;19:465-80.
62. Sivanandam TM, Thakur MK. Traumatic brain injury: A risk factor for Alzheimer's disease. Neurosci Biobehav Rev 2012;36:1376-81.
63. Dickstein DL, Walsh J, Brautigam H, Stockton SD, Gandy S, Hof PR. Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. Mt Sinai J Med 2010;77:82-102.
64. Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, et al. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 2009;302:2565-72.
65. Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nature Rev. Neurosci 2010;6:131-44.
66. Reddy MM, Wilson R, Wilson J, Connell S, Gocke A, Hynan L, et al. Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening. Cell 2011;144:132-42.
67. Zlot A, Newell A, Silvey K, Arail K. Addressing the obesity epidemic: a genomics perspective. Prev Chronic Dis 2007;4: 1-6.
68. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index of twins who have been reared apart. N Engl J Med 1990;322:1483-87.
69. Stunkard AJ, Sørensen TI, Hanis C, Teasdale TW, Chakraborty R, Schull WJ, et al. An adoption study of human obesity. N Engl J Med 1986;314:193-98.
70. Travers ME, McCarthy MI. Type 2 diabetes and obesity: genomics and the clinic. Hum Genet 2011;130:41-58.
71. Feero WG, Guttmacher AE, McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010;363:2339-50.
72. Mao P. Recent advances in obesity: genetics and beyond. ISRN Endocrinology 2012;2012.
73. Paquot N, De Flines J, Rorive M. Obesity: a model of complex interactions between genetics and environment]. Revue médicale de Liège 2012;67:332-36.
74. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J-I, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
75. Bouchard L, Tchernof A, Deshaies Y, Marceau S, Lescelleur O, Biron S. ZFP36: a promising candidate gene for obesity-related metabolic complications identified by converging genomics. Obes Surg 2007;17:372-82.
76. Loos R, Bouchard C. FTO: the first gene contributing to common forms of human obesity. Obes Rev 2008;9:246-50.
77. Lu Y, Loos RJ. Obesity genomics: assessing the transferability of susceptibility loci across diverse populations. Genome Medicine 2013;5:1-14.
78. Rask-Andersen M. Obesity Genetics: Functional Aspects of Four Genetic Loci Associated with Obesity and Body Mass [Dissertation]. Acta Universitatis Upsaliensis. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 2013;921: 48.
79. Gutierrez-Aguilar R, Kim DH, Woods SC, Seeley RJ. Expression of new loci associated with obesity in diet induced obese rats: from genetics to physiology. Obesity 2012;20:306-12.
80. Orešič M. Obesity and psychotic disorders: uncovering common mechanisms through metabolomics. Dis Model Mech 2012;5:614-20.
81. Zhang A, Sun H, Wang X. Power of metabolomics in biomarker discovery and mining mechanisms of obesity. Obes Rev 2013;14:344-49.
82. Welthagen W, Shellie RA, Spranger J, Ristow M, Zimmermann R, Fiehn O. Comprehensive twodimensional gas chromatography-time-of-flight mass spectrometry (GC× GC-TOF) for high resolution metabolomics: biomarker discovery on spleen tissue extracts of obese NZO compared to lean C57BL/6 mice. Metabolomics 2005;1:65-73.
83. Kirkwood JS, Legette LL, Miranda CL, Jiang Y, Stevens JF. A metabolomics driven elucidation of the anti-obesity mechanisms of xanthohumol. J Biol Chem. 2013;288:19000-13.
84. Wahl S, Holzapfel C, Yu Z, Breier M, Kondofersky I, Fuchs C, et al. Metabolomics reveals determinants of weight loss during lifestyle intervention in obese children. Metabolomics 2013:1-11.
85. Wang J, Li D, Dangott LJ, Wu G. Proteomics and its role in nutrition research. J Nutr 2006;136:1759-62.
86. Zamanian-Azodi M, Rezaie-Tavirani M, Heydari-Kashal S, Kalantari S, Dailian S, Zali H. Proteomics analysis of MKN45 cell line before and after treatment with Lavender aqueous extract. Gastroenterol Hepatol Bed Bench. 2011;5:35-42.
87. Peinado JR, Pardo M, de la Rosa O, Malagón MM. Proteomic characterization of adipose tissue constituents, a necessary step for understanding adipose tissue complexity. Proteomics 2012;12:607-20.
88. Renes J, Mariman E. Application of proteomics technology in adipocyte biology. Mol BioSyst 2013;9:1076-91.
89. Hittel DS, Hathout Y, Hoffman EP. Proteomics and systems biology in exercise and sport sciences research. Exerc Sport Sci. 2007;35:5-11.
90. Peral B, Camafeita E, Fernández-Real J-M, López JA. Tackling the human adipose tissue proteome to gain insight into obesity and related pathologies. Expert Rev Proteomics 2009;6:353-61.
91. Kim OY, Shin M-J, Moon J, Chung JH. Plasma ceruloplasmin as a biomarker for obesity: a proteomic approach. Clin Biochem 2011;44:351-56.
92. Tvarijonaviciute A, Gutiérrez A, Miller I, Razzazi-Fazeli E, Tecles F, Ceron J. A proteomic analysis of serum from dogs before and after a controlled weightloss program. Domest Anim Endocrin 2012;43:271-77.
93. Moest H, Frei AP, Bhattacharya I, Geiger M, Wollscheid B, Wolfrum C. Malfunctioning of adipocytes in obesity is linked to quantitative surfaceome changes. Biochim Biophys Acta 2013;1831:1208-16